雅各臣科研制药（02633.HK）今日盘中大涨7.04%，引起市场广泛关注。截至盘中，该股报1.500港元/股，成交量73万股，换手率0.04%，振幅3.52%。
股价上涨的主要原因是公司发布了积极的年度业绩报告。根据公告，雅各臣科研制药截至2025年3月31日止年度的持续经营业务收益约15.77亿港元，同比增长7.4%。更值得注意的是，公司权益持有人应占溢利约3.01亿港元，同比大幅增长12.69%，每股盈利达15.15港仙。
此外，公司还宣布了可观的股息分配计划，拟派末期现金股息每股5.50港仙及特别现金股息每股6.00港仙，这无疑增强了投资者的信心。雅各臣科研制药作为一家专注于非专利药及中成药制造和销售的香港公司，此次业绩增长显示出其在市场中的竞争力正在不断提升。分析人士认为，公司稳健的财务表现和慷慨的分红政策是推动股价上涨的关键因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.